Pretransplantation GAD-Autoantibody Status to Guide Prophylactic Antibody Induction Therapy in Simultaneous Pancreas and Kidney Transplantation

@article{Ringers2013PretransplantationGS,
  title={Pretransplantation GAD-Autoantibody Status to Guide Prophylactic Antibody Induction Therapy in Simultaneous Pancreas and Kidney Transplantation},
  author={J. Ringers and C. R. van der Torren and P. van de Linde and P. V. D. van der Boog and M. Mallat and E. Bonifacio and B. Roep and J. D. de Fijter},
  journal={Transplantation Journal},
  year={2013},
  volume={96},
  pages={745–752}
}
Background Daclizumab and antithymocyte globulin (ATG) have been shown to reduce allograft rejection. We assessed the safety and efficacy of daclizumab or ATG prophylaxis in combination with triple immunotherapy in simultaneous pancreas-kidney transplant (SPKT) recipients. Methods Thirty-nine type 1 diabetic patients scheduled for primary SPKT were randomized to receive prophylactic therapy with either daclizumab or ATG. A group of 27 patients without prophylactic antibodies was used for… Expand
Alemtuzumab Induction and Delayed Acute Rejection in Steroid-Free Simultaneous Pancreas-Kidney Transplant Recipients
Risk Factors for Type 1 Diabetes Recurrence in Immunosuppressed Recipients of Simultaneous Pancreas–Kidney Transplants
  • F. Vendrame, Y. Hopfner, +11 authors A. Pugliese
  • Medicine
  • American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
  • 2016

References

SHOWING 1-10 OF 58 REFERENCES
Rabbit antithymocyte globulin versus basiliximab in renal transplantation.
...
1
2
3
4
5
...